Influence of hepatic impairment on the pharmacokinetics and pharmacodynamics of the P2Y12 receptor antagonist selatogrel

Abstract Selatogrel is a potent and selective reversible P2Y12 receptor antagonist in development for early treatment of acute myocardial infarction via subcutaneous (s.c.) self‐injection. Selatogrel is almost exclusively eliminated via the hepatobiliary route. Hepatic impairment is associated with...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Uta Schilling (Dahkki), Chih‐Hsuan Hsin (Dahkki), Stephane Delahaye (Dahkki), Andreas Krause (Dahkki), Hauke Wuelfrath (Dahkki), Atef Halabi (Dahkki), Jasper Dingemanse (Dahkki)
Materiálatiipa: Girji
Almmustuhtton: Wiley, 2022-08-01T00:00:00Z.
Fáttát:
Liŋkkat:Connect to this object online.
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Interneahtta

Connect to this object online.

3rd Floor Main Library

oažžasuvvan: 3rd Floor Main Library
Hildobáiki: A1234.567
Njađus 1 Oažžumis